Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
symbol | company | %chng | last | %short | avg$volume | |
---|---|---|---|---|---|---|
CELG | Celgene Corporation | -1.94% | 88.65 | 1.3% | $803.98m | |
AMGN | Amgen Inc. | -0.76% | 185.50 | 1.2% | $628.99m | |
GILD | Gilead Sciences, Inc. | -2.14% | 65.55 | 0.9% | $482.29m | |
BIIB | Biogen Inc. | -4.17% | 321.17 | 1.3% | $427.44m | |
ILMN | Illumina, Inc. | -1.77% | 296.88 | 3.5% | $311.35m | |
REGN | Regeneron Pharmaceuticals, Inc. | -0.92% | 418.62 | 2.6% | $290.18m | |
VRTX | Vertex Pharmaceuticals Incorporated | -2.55% | 183.06 | 1.9% | $253.58m | |
ALXN | Alexion Pharmaceuticals, Inc. | -1.76% | 127.55 | 2.0% | $219.68m | |
SRPT | Sarepta Therapeutics, Inc. | -2.87% | 136.54 | 15.4% | $152.33m | |
A | Agilent Technologies, Inc. | -0.83% | 77.91 | 1.6% | $150.84m | |
EXAS | Exact Sciences Corporation | -0.42% | 83.28 | 25.3% | $132.28m | |
INCY | Incyte Corporation | -0.49% | 83.33 | 2.5% | $111.93m | |
ARRY | Array BioPharma Inc. | -1.99% | 22.71 | 8.2% | $108.01m | |
EXEL | Exelixis, Inc. | -0.09% | 21.22 | 6.4% | $82.07m | |
NBIX | Neurocrine Biosciences, Inc. | -2.58% | 77.31 | 5.1% | $77.22m |
Company Profile
Aravive, Inc. is a clinical stage biotechnology company focused on developing innovative therapies that target treatment for cancer. Its product portfolio include AVB-S6-500 which is a soluble Fc-fusion protein designed to block the activation of the GAS6-AXL signaling pathway by intercepting the binding of GAS6 to its receptor AXL which also promotes metastasis, cancer cell survival, resistance to treatments, and immune suppression. The company was founded on July 6, 2016 and is headquartered in Houston, TX.